The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

Nasdaq, Coinbase, Citi, NAB and Chicago Trading Company were among the participants in the crypto data company's latest round.

The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

Web3 services provider Venly and genomic analysis technology provider Genome Insight each raised $23m while Rui Ye Lian helped Cedarlake Capital close a $189m fund.

The small business fintech platform received backing from PayPal to expand across Latin America.

Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.

Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.

Vishal Gupta, formerly a director at the SoftBank division that oversees its Vision Funds, has joined TA Associates in a similar role.

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

Massachusetts Mutual Life's venture capital arm has formed a fourth fund, which will concentrate on European and Asia-Pacific investments.